Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

Author:

Takemura KosukeORCID,Lemelin Audreylie,Ernst Matthew S.,Wells J. Connor,Saliby Renee Maria,El Zarif Talal,Labaki Chris,Basappa Naveen S.,Szabados Bernadett,Powles Thomas,Davis Ian D.,Wood Lori A.,Lalani Aly-Khan A.,McKay Rana R.,Lee Jae-Lyun,Meza Luis,Pal Sumanta K.,Donskov Frede,Yuasa Takeshi,Beuselinck Benoit,Gebrael Georges,Agarwal Neeraj,Choueiri Toni K.,Heng Daniel Y.C.

Funder

National Health and Medical Research Council

Yasuda Memorial Medical Foundation

Publisher

Elsevier BV

Subject

Urology

Reference10 articles.

1. Sunitinib in metastatic renal cell carcinoma patients with brain metastases;Gore;Cancer,2011

2. Clinical outcomes in patients with metastatic renal cell carcinoma and brain metastasis treated with ipilimumab and nivolumab;Brown;J Immunother Cancer,2021

3. A randomized trial of surgery in the treatment of single metastases to the brain;Patchell;N Engl J Med,1990

4. Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis;Lamba;Radiat Oncol,2017

5. Effectiveness of immune checkpoint inhibitors in combination with stereotactic radiosurgery for patients with brain metastases from renal cell carcinoma: inverse probability of treatment weighting using propensity scores;Yomo;J Neurosurg,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3